臉部注射劑的全球市場 - 市場規模，佔有率，成長分析:各類型(肉毒桿菌，膠原蛋白)，各用途(皺紋改善，拉皮)，各終端用戶(醫院，門診病人手術中心) - 產業預測(2023年～2030年)

Global Facial Injectables Market Size, Share, Growth Analysis, By Type(Botulinum Toxin, Collagen), By Application(Wrinkle Reduction, Facelift), By End-User(Hospitals, Ambulatory Surgery Centers) - Industry Forecast 2023-2030

出版日期: 2023年07月11日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

臉部注射劑的市場規模在2021年估算為161億美元，2022年為175億6,000萬美金。該市場在預測期間內(2023年～2030年)時將以9.1％的年複合成長率擴大，2030年擴大到344億9,000萬美元。

受人們對年輕外表的日益渴望和美容治療意識不斷提高等因素的推動，全球面部注射劑市場正在經歷顯著增長。面部注射劑包括真皮填充劑和肉毒毒素，廣泛用於除皺、豐唇和麵部護理。技術的進步、可支配收入的增長和審美意識的增強推動了市場的發展。對微創手術的需求不斷增長，人口老齡化不斷加劇，預計將在未來幾年進一步推動市場的增長。

本報告提供全球臉部注射劑市場相關調查，提供市場概要，以及各類型，各用途，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

主要企業簡介
- Allergan
- Galderma S.A.
- Merz Pharma
- Sanofi S.A.
- Sinclair Pharma
- Suneva Medical
- Teoxane Laboratories
- Anika Therapeutics
- Anteis S.A.
- BioPolymer GmbH &Co. KG
- Cynosure, Inc.
- Ipsen Group
- Medytox, Inc.
- Polymekon s.r.o.
- Prollenium Medical Technologies Inc.
- Q-Med AB
- Revance Therapeutics, Inc.
- SciVision Biotech Inc.
- Syneron Medical Ltd.
- VisionMed Inc

簡介目錄

Product Code: SQSG35I2006

Facial Injectables Market size was valued at USD 16.1 billion in 2021 and is poised to grow from USD 17.56 billion in 2022 to USD 34.49 billion by 2030, growing at a CAGR of 9.1% in the forecast period (2023-2030).

The global facial injectables market is experiencing significant growth, driven by factors such as the increasing desire for youthful appearance and rising awareness of aesthetic treatments. Facial injectables, including dermal fillers and botulinum toxin, are widely used for wrinkle reduction, lip augmentation, and facial contouring. The market is fueled by advancements in technology, growing disposable income, and expanding aesthetic consciousness. Rising demand for minimally invasive procedures and the growing aging population are expected to further drive the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Facial Injectables and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The global facial injectables market is segmented based on type, application, end-user, and region. Based on type, the facial injectables market is segmented as botulinum toxin, collagen, hyaluronic acid, calcium hydroxyl apatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, others. Based on application, the facial injectables market is segmented as wrinkle reduction, facelift, acne scar therapy, lip augmentation, lipoatrophy treatment, others. Based on end-users, the market is segmented as hospitals and ambulatory surgery centers, dermatology and cosmetic clinics, and others. Based on region, the facial injectables market segmentation spans North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

During the projected period, the demand for facial injectables is expected to increase due to the detrimental effects of environmental pollutants and diverse lifestyle choices on skin health. These injectables consist of collagen fibers, hyaluronic acid fillers, and synthetic fillers..

Restrain

However, the expansion of the market is hindered by stringent regulations, limitations on product usage, and the occurrence of skin issues such as rashes and redness. These obstacles impede the market's growth, particularly in terms of aesthetic applications

Trend

A notable trend in the market is the growing adoption of facial injectables among men. Over the forecast period, it is expected that men will increasingly embrace various fillers, including botulinum toxin and dermal fillers. For example, younger men are choosing tissue fillers as a means to combat aging. This increasing acceptance of facial injectables among the male population is likely to contribute to their higher usage.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Facial Injectables Market by Type
- Market Overview
- Botulinum Toxin
- Collagen
- Hyaluronic Acid
- Calcium Hydroxyl Apatite
- Polylactic Acid
- Polymethyl-Methacrylate Microspheres (PMMA)
- Fat Injection
- Others
Global Facial Injectables Market by Application
- Market Overview
- Wrinkle Reduction
- Facelift
- Acne Scar Therapy
- Lip Augmentation
- Lipoatrophy Treatment
- Others
Global Facial Injectables Market by End-User
- Market Overview
- Hospitals
- Ambulatory Surgery Centers
- Dermatology
- Cosmetic Clinics
- Others
Global Facial Injectables Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Allergan
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galderma S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merz Pharma
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sinclair Pharma
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Suneva Medical
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teoxane Laboratories
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Anika Therapeutics
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Anteis S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioPolymer GmbH & Co. KG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cynosure, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ipsen Group
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medytox, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Polymekon s.r.o.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Prollenium Medical Technologies Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Q-Med AB
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Revance Therapeutics, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- SciVision Biotech Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Syneron Medical Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- VisionMed Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments